ArticleKidney international reports2021

Erratum to "Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis - Subgroup Analyses of the CALIPSO Trial." Kidney Int. Rep. 2020;5:2178-2182.

No numbers read from the abstract.

Not cited yet